This opinion essay was published on April 5, 2024, in The Boston Globe's healthcare affiliate, STAT.

Morehouse School of Medicine's Dr. James Lillard underlines the significance of new PMC findings outlining how researchers and policymakers can promote more diversity and inclusion in biomedical research.

PMC Senior Vice President for Public Policy Cynthia A. Bens introduces the Coalition's 2024 Policy Agenda.

PMC President Edward Abrahams and Board Chairman Lincoln Nadauld introduce the Coalition's 2023 - 2024 Impact Report.

PMC Senior Vice President for Public Affairs Christopher J. Wells previews the potential impact of the Coalition's 2024 public affairs programs.

PMC President Edward Abrahams shares the Coalition's Strategic Plan for Advancing Personalized Medicine in 2024.

PMC Senior Vice President for Public Affairs Christopher J. Wells summarizes the impact of the 17th Annual Personalized Medicine Conference.

PMC President Edward Abrahams responds to the August 6, 2023, article in The New York Times titled "Personalized Medicine’s False Promise."

PMC President Edward Abrahams provides an update on the state of the Coalition as PMC celebrates its 20th anniversary this year.

PMC Senior Vice President for Public Policy Cynthia A. Bens defines PMC's positions on several issues that have emerged as top priorities for lawmakers and agency officials in recent years.

PMC Senior Vice President for Public Affairs Christopher J. Wells reflects on what U.S. National Human Genome Research Institute Director Dr. Eric Green's May 24 keynote address on the state of personalized medicine means — for the field and for PMC.

PMC Senior Vice President for Public Affairs Christopher J. Wells provides an update on the Coalition's enhanced capacity for impacting the public dialogue about the future of health care.